Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Universidade Federal de São Paulo/Escola Paulista de Medicina, São Paulo, Brazil. lpmpcorreia@gmail.com
Inflammatory bowel disease is relatively frequent in women of childbearing age. Disease management requires greater attention during this clinical condition because of potential risk of maternal-fetal complications. Infliximab has been shown to be safe during pregnancy and lactation, but reports in the literature are scarce. We report two cases of refractory Crohn's disease treated with infliximab with good results, in women. Both patients became pregnant during maintenance regimen and treatment was continued. The literature regarding pregnant patients with inflammatory bowel disease was reviewed.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on